These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37175288)

  • 1. Unlocking the Conformational Changes of P2Y
    Al-Najjar BO; Saqallah FG
    Molecules; 2023 May; 28(9):. PubMed ID: 37175288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovering novel inhibitors of P2Y
    Halim SA; Waqas M; Asim A; Khan M; Khan A; Al-Harrasi A
    Comput Biol Med; 2022 Aug; 147():105743. PubMed ID: 35772327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the binding mechanism of novel 6-aminonicotinate-based antagonists with P2Y
    Zhou S; Fang D; Tan S; Lin W; Wu W; Zheng K
    J Biomol Struct Dyn; 2017 Oct; 35(13):2938-2965. PubMed ID: 27634290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse agonist efficacy of selatogrel blunts constitutive P2Y12 receptor signaling by inducing the inactive receptor conformation.
    Pons V; Garcia C; Tidten-Luksch N; Mac Sweeney A; Caroff E; Galés C; Riederer MA
    Biochem Pharmacol; 2022 Dec; 206():115291. PubMed ID: 36306820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-bound structure of the human P2Y12 receptor.
    Zhang J; Zhang K; Gao ZG; Paoletta S; Zhang D; Han GW; Li T; Ma L; Zhang W; Müller CE; Yang H; Jiang H; Cherezov V; Katritch V; Jacobson KA; Stevens RC; Wu B; Zhao Q
    Nature; 2014 May; 509(7498):119-22. PubMed ID: 24784220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of action for reversible P2Y12 antagonists.
    Liu H; Ge H; Peng Y; Xiao P; Xu J
    Biophys Chem; 2011 May; 155(2-3):74-81. PubMed ID: 21440362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the human P2Y12 receptor in complex with an antithrombotic drug.
    Zhang K; Zhang J; Gao ZG; Zhang D; Zhu L; Han GW; Moss SM; Paoletta S; Kiselev E; Lu W; Fenalti G; Zhang W; Müller CE; Yang H; Jiang H; Cherezov V; Katritch V; Jacobson KA; Stevens RC; Wu B; Zhao Q
    Nature; 2014 May; 509(7498):115-8. PubMed ID: 24670650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking-based virtual screening of potential human P2Y12 receptor antagonists.
    Chen H; Dong X; Zhou M; Shi H; Luo X
    Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):400-8. PubMed ID: 21474491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y
    Boncler M; Wzorek J; Wolska N; Polak D; Watala C; Rozalski M
    Vascul Pharmacol; 2019 Feb; 113():47-56. PubMed ID: 30471364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?
    Delesque-Touchard N; Pflieger AM; Bonnet-Lignon S; Millet L; Salel V; Boldron C; Lassalle G; Herbert JM; Savi P; Bono F
    Thromb Res; 2014 Sep; 134(3):693-703. PubMed ID: 25064036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2Y
    Al-Najjar BO; Saqallah FG; Abbas MA; Al-Hijazeen SZ; Sibai OA
    Eur J Med Chem; 2022 Jan; 227():113924. PubMed ID: 34731765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.
    Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ
    Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
    Hao M; Li Y; Wang Y; Yan Y; Zhang S; Li G; Yang L
    J Chem Inf Model; 2011 Oct; 51(10):2560-72. PubMed ID: 21923153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information.
    Paoletta S; Sabbadin D; von Kügelgen I; Hinz S; Katritch V; Hoffmann K; Abdelrahman A; Straßburger J; Baqi Y; Zhao Q; Stevens RC; Moro S; Müller CE; Jacobson KA
    J Comput Aided Mol Des; 2015 Aug; 29(8):737-56. PubMed ID: 26194851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y
    Gündüz D; Tanislav C; Sedding D; Parahuleva M; Santoso S; Troidl C; Hamm CW; Aslam M
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a New Morpholine Scaffold as a P2Y12 Receptor Antagonist.
    Ahn YH; Lee JY; Park HD; Kim TH; Park MC; Choi G; Kim S
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27563870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic P2Y
    Baqi Y; Müller CE
    Drug Discov Today; 2019 Jan; 24(1):325-333. PubMed ID: 30291899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide.
    Kirkby NS; Lundberg MH; Chan MV; Vojnovic I; Solomon AB; Emerson M; Mitchell JA; Warner TD
    Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15782-7. PubMed ID: 24003163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y
    Hensch NR; Karim ZA; Pineda J; Mercado N; Alshbool FZ; Khasawneh FT
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1069-1074. PubMed ID: 28928091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and analysis of functionally important amino acids in human purinergic 12 receptor using a Saccharomyces cerevisiae expression system.
    Ignatovica V; Megnis K; Lapins M; Schiöth HB; Klovins J
    FEBS J; 2012 Jan; 279(1):180-91. PubMed ID: 22044483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.